Changes in haematocrit in patients with acute myocardial infarction are the subject of several reports. Burch and DePasquale (1962) and DePasquale and Burch (1963) suggested that the peripheral venous haematocrit was raised in acute myocardial infarction. This was not confirmed by subsequent studies (Conley et al., 1964; Vuopio and Eisalo, 1964) but has recently been supported (Stables et al., 1967) . It has also been suggested that a fall in haematocrit may occur during the first few days of the acute illness (Conley et al., 1964; Vuopio and Eisalo, 1964) .
With recent interest in the treatment of cardiac infarction by infusions of various solutions, the physiology of haematocrit and plasma volume becomes more important. In the course of haemodynamic study of patients with acute myocardial infarction we have routinely measured central venous haematocrit, and high values and large changes during the first few days after the onset of symptoms have been noted frequently.
The purpose of this paper is to document these observations together with plasma volume measurements made in selected patients. Possible physiological mechanisms responsible for the haematocrit changes and their relevance to infusion treatment of patients with acute myocardial infarction are discussed.
SUBJECTS AND METHODS
Twenty-seven patients, 23 men 4 women, with unequivocal clinical and electrocardiographic evidence of acute myocardial infarction, admitted to the coronary care unit (Shillingford and Thomas, 1964) , were studied. Ages ranged from 46 to 73, mean 59-7 years. Twentyfive patients (Table I) were selected on the basis of one arbitrary criterion-a central venous haematocrit equal to or greater than 47 per cent on at least one occasion during the first week of illness. Three patients had a history of chronic bronchitis but no evidence of serious lung disease. Two or more measurements were made in all patients except three who died within 24 hours.
The first measurements were made when the patient was admitted to hospital. In all except six patients this was within 24 hours of the onset of symptoms. Subsequent investigations, as far as possible, were made at the same time of day.
Haematocrit was measured by the Wintrobe method. Central venous blood was taken via an indwelling polyethylene catheter and transferred into heparinized tubes. An aliquot was centrifuged in a Wintrobe tube at 3000 r.p.m. for 30 minutes. The radius from the centrifuge axis to the tip of the tube was 15 cm.
Serial measurements of plasma volume were made in two patients selected from those in Table I and 24) and in two other patients, all men. Plasma volume was measured by the use of radioactive 131I human serum albumin (RIHSA), which was dialysed before use. RIHSA (between 7 and 20 ,uCi) was injected from a calibrated syringe into the centtal venous system via the catheter. Blood samples were taken at 10, 15, 20, and 25 minutes. The catheter was washed with blood and saline before and after injection and sampling. The amount of RIHSA solution injected was determined by injecting the same volume from the same syringe through a similar blood and saline washed catheter into a 1000 ml. flask containing saline and 10 ml. concentrated detergent solution (Teepol) (Reeve and Franks, 1956 ). This was made up to 1000 ml. and the radioactivity of an aliquot determined.
For the final calculation of plasma volume, the plasma radioactivity at "zero time", obtained by extrapolation, was used.
Radiological evidence of pulmonary oedema was graded 1-4 according to severity.
RESULTS
Haematocrit Changes. Values of haematocrit and the times at which they were obtained are given in Table I . The time scale was made with reference to the onset of symptoms.
Haematocrit on the first day ranged from 46 to 59 per cent; on the second day from 43 to 54 per cent; on the third day from 39 to 59 per cent; on the fourth day from 44 to 57 per cent and on the fifth day from 43 to 53 per cent.
A change of 3 per cent or more in haematocrit during the first week of the illness occurred in 17 patients. In 15 of these, later values were lower than initial values. An example of falling haematocrit in one of these patients (Case 13) is given in Fig. 1 . Two patients (Cases 6, 20) showed an increase in haematocrit during the first two days but in one of these (Case 6) a fall of more than 3 per cent followed. An example of increase of haematocrit (Case 20) is given in Fig. 2 .
The general clinical state of patients in this group during the period of haematocrit measurement is indicated in Table II. Plasma Volume Patient A (Case 22). A man aged 58, with acute antero-lateral infarction, initially had marked pulmonary oedema, and clinical improvement was later followed by cardiac arrest and resuscitation. Subsequently a shock syndrome developed. The early clinical improvement with resolution in pulmonary oedema was associated with a fall in haematocrit from 49 to 37 per cent (Fig. 3) . At the same time plasma volume rose from 30 to 39 ml./kg. Although pulmonary oedema resolved, the heart size, assessed by cardiothoracic ratio, increased from 0'52 to 0-60. The lung fields remained clear for 8 days until cardiac arrest on the 18th day. Plasma volume fell from 39 ml./kg., 3 hours preceding arrest, to 34 ml./kg., 16 hours afterwards. Haematocrit did not change. The clinical features after cardiac arrest included gross pulmonary oedema, the shock syndrome, and further cardiac enlargement. Six days later he again had cardiac arrest and died. (Rose et al., 1962) . This effect might be responsible for changes in plasma volume and haematocrit (Albert, 1963) .
The significance of the haematocrit and plasma volume changes with respect to infusion treatment of patients with acute myocardial infarction is not clearly defined. This study suggests that the formation of pulmonary oedema is associated with a fall in plasma volume, but it is likely that changes of similar magnitude occur in less seriously ill patients as well as the patients who are most ill with the shock syndrome. Whether the plasma volume fall in itself calls for replacement treatment is debatable but continued study is necessary to show whether infusions confer benefit by other mechanisms. 
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